The effects of dried tomato pomace and a multipleenzyme mixture supplementation (Rovabio ExcelTM) on performance and carcass quality of broiler chickens

An experiment was conducted to study the effect of dried tomato pomace (DTP) and a multienzyme preparation supplementation (Rovabio ExcelTM) on the performance and carcass quality of broiler chickens. A 4 × 2 factorial arrangement of treatments comprising 4 dietary DTP levels (0, 8, 16 and 24%) with and without enzyme supplementation was used. Each diet was fed to 4 replicates pens of 8 broiler chicks from 1 to 42 days posthatch as a coarse mash. The addition of DTP up to 16% to broiler diets did not significantly affect feed intake (FI), body weight gain (BWG) and feed conversion ratio (FCR) during starter (1 to 21 days), growing (22 to 42 days) and entire experimental (1 to 42 days) periods. Inclusion of 24% DTP into the diet significantly decreased FI at starter and entire experimental periods. Also, inclusion of 24% DTP into the diets significantly decreased BWG and increased FCR at all periods. Birds fed the diets supplemented with Rovabio ExcelTM had significantly higher BWG during the starter and entire experimental periods. No significant effect of enzyme addition was observed on FI and FCR. The dietary treatments with or without enzyme did not significantly affect mortality. The 8% DTP-fed group had comparable carcass weight, carcass yield, yield of breast, thigh, abdominal fat, heart, liver and gizzard with those of control group. The higher levels of DTP significantly decreased carcass weight and yield, yield of breast and thigh when compared to the control group. Enzyme supplementation significantly increased carcass weight and yield of abdominal fat. No significant interactions between the DTP and enzyme were observed for performance parameters and carcass characteristics. These results demonstrate that supplementation of DTP up to 8% to broiler diets had no significant adverse effects on performance parameters and carcass characteristics. The enzyme had a significant effect on BWG, carcass weight and yield of abdominal fat.Key words: Dried tomato pomace, enzyme, performance, carcass quality, broiler

Controversies in the Use of MIGS

Abstract Minimally invasive glaucoma surgery (MIGS) has fulfilled an unmet need in the management of glaucoma. This chapter highlights some controversial issues regarding the use of MIGS in clinical practice, including (1) whether there is sufficient evidence to advocate combining MIGS with cataract surgery over cataract surgery alone, (2) the merits and drawbacks of different approaches to trabecular bypass and canal-based MIGS procedures, (3) the effect of MIGS on endothelial cell loss, (4) suprachoroidal MIGS devices and whether there is still a role for these procedures, and (5) a comparison between subconjunctival MIGS and trabeculectomy. Several questions are still left unanswered and hopefully, further research and more clinical experience with these new technologies will help improve surgical outcomes for patients

Evolution of cyclophotocoagulation

Cyclodestructive techniques have been a treatment option for refractory glaucoma since its first use in the 1930s. Over the past nine decades, cyclodestruction has advanced from the initial cyclodiathermy to micropulse transscleral cyclophotocoagulation (MP-TSCPC) which is the current treatment available. Complications associated with cyclodestruction including pain, hyphema, vision loss, hypotony and phthisis have led ophthalmologists to shy away from these techniques when other glaucoma treatment options are available. Recent studies have shown encouraging clinical results with fewer complications following cyclophotocoagulation, contributing greatly to the current increase in the use of cyclophotocoagulation as primary treatment for glaucoma. We performed our literature search on Google Scholar Database, Pubmed, Web of Sciences and Cochrane Library databases published prior to September 2017 using keywords relevant to cyclodestruction, cyclophotocoagulation and treatment of refractory glaucoma